Skip to main content
Notice2026-06935

Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
April 10, 2026

Issuing agencies

Health and Human Services DepartmentFood and Drug Administration

Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's regulations for submission of petitions, including food and color additive petitions (including labeling), submission of information to a master file in support of petitions, and electronic submission using Form FDA 3503.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 69 (Friday, April 10, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 69 (Friday, April 10, 2026)]
[Notices]
[Pages 18466-18468]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-06935]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2026-N-2743]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Submission of Petitions: Food Additive, Color Additive 
(Including Labeling), Submission of Information to a Master File in 
Support of Petitions; and Electronic Submission Using Food and Drug 
Administration Form 3503

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
an opportunity for public comment on the proposed collection of certain 
information by the Agency. Under the Paperwork Reduction Act of 1995 
(PRA), Federal Agencies are required to publish notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, and 
to allow 60 days for public comment in response to the notice. This 
notice solicits comments on the information collection provisions of 
FDA's regulations for submission of petitions, including food and color 
additive petitions (including labeling), submission of information to a 
master file in support of petitions, and electronic submission using 
Form FDA 3503.

DATES: Either electronic or written comments on the collection of 
information must be submitted by June 9, 2026.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. The <a href="https://www.regulations.gov">https://www.regulations.gov</a> electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of June 9, 2026. Comments received 
by mail/hand delivery/courier (for written/paper submissions) will be 
considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
    <bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to <a href="https://www.regulations.gov">https://www.regulations.gov</a> 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
    <bullet> If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
    <bullet> Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
    <bullet> For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2026-N-2743 for ``Agency Information Collection Activities; 
Proposed Collection; Comment Request; Submission of Petitions: Food 
Additive, Color Additive (Including Labeling), Submission of 
Information to a Master File in Support of Petitions; and Electronic 
Submission Using Food and Drug Administration Form 3503.'' Received 
comments, those filed in a timely manner (see ADDRESSES), will be 
placed in the docket and, except for those submitted as ``Confidential 
Submissions,'' publicly viewable at <a href="https://www.regulations.gov">https://www.regulations.gov</a> or at 
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through 
Friday, 240-402-7500.
    <bullet> Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly

[[Page 18467]]

available, you can provide this information on the cover sheet and not 
in the body of your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: <a href="https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf">https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf</a>.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT: Michael Ellison, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 240-402-2093, 
<a href="/cdn-cgi/l/email-protection#bbebe9fae8cfdaddddfbdddfda95d3d3c895dcd4cd"><span class="__cf_email__" data-cfemail="520200130126333434123436337c3a3a217c353d24">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal 
Agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes Agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal Agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, 
before submitting the collection to OMB for approval. To comply with 
this requirement, FDA is publishing notice of the proposed collection 
of information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

Submission of Petitions: Food Additive, Color Additive (Including 
Labeling), Submission of Information to a Master File in Support of 
Petitions; and Electronic Submission Using Form FDA 3503--21 CFR 21 CFR 
70.25, 71.1, and 171.1 and 21 CFR Parts 172, 173, 179, and 180

OMB Control Number 0910-0016--Extension

    Section 409(a) of the Federal Food, Drug, and Cosmetic Act (FD&C 
Act) (21 U.S.C. 348(a)) provides that a food additive shall be deemed 
to be unsafe, unless: (1) the additive and its use, or intended use, 
are in conformity with a regulation issued under section 409 that 
describes the condition(s) under which the additive may be safely used; 
(2) the additive and its use, or intended use, conform to the terms of 
an exemption for investigational use; or (3) a food contact 
notification submitted under section 409(h) is effective. Food additive 
petitions (FAPs) are submitted by individuals or companies to obtain 
approval of a new food additive or to amend the conditions of use 
permitted under an existing food additive regulation. Section 171.1 of 
FDA's regulations (21 CFR 171.1) specifies the information that a 
petitioner must submit in order to establish that the proposed use of a 
food additive is safe and to secure the publication of a food additive 
regulation describing the conditions under which the additive may be 
safely used. Parts 172, 173, 179, and 180 (21 CFR parts 172, 173, 179, 
and 180) contain labeling requirements for certain food additives to 
ensure their safe use.
    Section 721(a) of the FD&C Act (21 U.S.C. 379e(a)) provides that a 
color additive shall be deemed to be unsafe unless the additive and its 
use are in conformity with a regulation that describes the condition(s) 
under which the additive may safely be used, or the additive and its 
use conform to the terms of an exemption for investigational use issued 
under section 721(f). Color additive petitions (CAPs) are submitted by 
individuals or companies to obtain approval of a new color additive or 
a change in the conditions of use permitted for a color additive that 
is already approved. Section 71.1 of the Agency's regulations (21 CFR 
71.1) specifies the information that a petitioner must submit to 
establish the safety of a color additive and to secure the issuance of 
a regulation permitting its use. FDA's color additive labeling 
requirements in Sec.  70.25 (21 CFR 70.25) require that color additives 
that are to be used in food, drugs, cosmetics, or medical devices be 
labeled with sufficient information to ensure their safe use.
    FDA scientific personnel review FAPs to ensure the safety of the 
intended use of the additive in or on food, or that may be present in 
food as a result of its use in articles that contact food. Likewise, 
FDA personnel review CAPs to ensure the safety of the color additive 
prior to its use in food, drugs, cosmetics, or medical devices.
    Respondents may transmit FAP or CAP regulatory submissions in 
electronic format or paper format to the Human Foods Program (HFP) 
using Form FDA 3503. Form FDA 3503 helps the respondent organize their 
submission to focus on the information needed for FDA's safety review. 
Form FDA 3503 can also be used to organize information within a master 
file submitted in support of petitions according to the items listed on 
the form. Master files can be used as repositories for information that 
can be referenced in multiple submissions to the Agency, thus 
minimizing paperwork burden for food and color additive approvals.
    We improved the information collection by using the HFP Centralized 
Online Submission Module (COSM). COSM provides a real-time user 
interface process that assists respondents in preparing and making 
submissions to HFP. COSM, available 24 hours a day and 7 days a week, 
is a web-based tool that supports electronic submissions, thereby 
eliminating the need for printing and mailing of paper submissions. 
Further information about COSM, including user instruction, is 
available on the internet at: <a href="https://www.fda.gov/food/registration-food-facilities-and-other-submissions/centralized-online-submission-module-cosm">https://www.fda.gov/food/registration-food-facilities-and-other-submissions/centralized-online-submission-module-cosm</a>.
    Description of Respondents: Respondents are businesses engaged in 
the manufacture or sale of food, food ingredients, color additives, or 
substances used in materials that come into contact with food.
    We estimate the burden of this collection of information as 
follows:

[[Page 18468]]



                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                               Total
                                                             Number of       Number of     Total annual   Average burden                   operating and
           Activity/21 CFR section; or form #               respondents    responses per     responses     per response     Total hours     maintenance
                                                                            respondent                                                         costs
--------------------------------------------------------------------------------------------------------------------------------------------------------
Submission of Petitions: Color Additive Including                      4               1               4           1,337           5,348         $11,200
 Labeling--70.25, 71.1..................................
Submission of Petitions: Food Additive Including                       3               1               3           7,093          21,279               0
 Labeling--171.1........................................
Form FDA 3503 \2\.......................................               5               1               5               1               5               0
                                                         -----------------------------------------------------------------------------------------------
    Total...............................................  ..............  ..............  ..............  ..............          26,632          11,200
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs associated with this collection of information.
\2\ Form FDA 3503 is used for both CAPs and FAPs.

    Based on a review of the information collection since our last 
request for OMB approval, we have adjusted our burden estimate for CAPs 
since the average number submitted has increased over the last 10 
years. Due to the increase of submissions, we estimate that 4 CAPs will 
be submitted annually. Thus, the estimated burden for the information 
collection reflects an overall increase of 2,674 hours. Our estimate of 
burden attributable to FAPs or CAPs is based on our experience with the 
information collection, which FAPs has not changed since our last 
review and reflects the average number of petitions we have received 
annually over a period of 10 years. The attendant burden we estimate 
also reflects an industry average, although burden associated with 
individual petitions may vary depending on the complexity of the 
petition, and the amount and type of data needed for scientific 
analysis.
    CAPs are subject to fees. The listing fee for a CAP ranges from 
$1,600 to $3,000, depending on the intended use of the color additive 
and the scope of the requested amendment. A complete schedule of fees 
is set forth in 21 CFR 70.19. An average of one Category A and one 
Category B CAP is expected per year. The maximum CAP fee for a Category 
A petition is $2,600, and the maximum CAP fee for a Category B petition 
is $3,000. Because an average of four CAPs are expected per calendar 
year, the estimated total annual operating and maintenance cost burden 
to petitioners for this startup cost would be less than or equal to 
$11,200 ((2 x $2,600) + (2 x $3,000) listing fees). There are no 
capital costs associated with CAPs.
    The labeling requirements for food and color additives were 
designed to specify the minimum information needed for labeling so that 
food and color manufacturers may comply with all applicable provisions 
of the FD&C Act and other specific labeling acts administered by FDA. 
Label information does not require any additional information gathering 
beyond what is already required to assure conformance with all 
specifications and limitations in any given food or color additive 
regulation. Label information does not have any specific recordkeeping 
requirements unique to preparing the label. Therefore, because labeling 
requirements under Sec.  70.25 for a particular color additive involve 
information required as part of the CAP safety review process, the 
estimate for number of respondents is the same for Sec. Sec.  70.25 and 
71.1, and the burden hours for labeling are included in the estimate 
for Sec.  71.1. Also, because labeling requirements under parts 172, 
173, 179, and 180 for particular food additives involve information 
required as part of the FAP safety review process under Sec.  171.1, 
the burden hours for labeling are included in the estimate for Sec.  
171.1.

Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-06935 Filed 4-9-26; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on April 10, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.